logo

For the Inventor, By the Inventor

Cambridge, United Kingdom

Andrew Peter Cridland

This inventor holds 20 USPTO granted patents and 3 EPO patents, primarily in Kinase Inhibitors. Top assignees: Chiesi Farmaceutici S.p.a., Genentech, Inc., Convergence Pharmaceuticals Limited. Active years: 2012-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew Peter Cridland. Retrieved from https://idiyas.com/inventor/andrew-peter-cridland

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20

% Patents Active = 5.0


Average Co-Inventor Count = 6.7

ph-index = 5

Forward Citations = 45(Granted Patents)


Location History:

  • Cambridge, GB (2014)
  • Harlow, GB (2012 - 2021)
  • Essex, GB (2018 - 2021)

Company Filing History:

goldMedal10 out of 342 
 
Chiesi Farmaceutici S.p.a.
 patents
silverMedal6 out of 3,300 
 
Genentech, Inc.
 patents
bronzeMedal4 out of 24 
 
Convergence Pharmaceuticals Limited
 patents

Years Active: 2012-2021

Loading Chart...
Loading Chart...
Areas of Expertise:
Pyridazine Derivatives
RORc Modulators
Oxadiazolones
Transient Receptor Potential
Triazolo Pyridine
P38 MAP Kinase
Calcium Channel Modulators
Piperazine Derivatives
Kinase Inhibitors
Drug Development
Cambridge
20 patents (USPTO):Explore Patents
1. 11008312 - Pyridazine derivatives as RORc modulators (2021-05-18),
2. 10913742 - Oxadiazolones as transient receptor potential channel inhibitors (2021-02-09),
3. 10487068 - Pyridazine derivatives as RORc modulators (2019-11-26),
4. 10280144 - Pyridazine derivatives as RORc modulators (2019-05-07),
5. 9994551 - Pyridazine derivatives as RORc modulators (2018-06-12),
6. 9981916 - Pyridazine derivatives as RORc modulators (2018-05-29),
7. 9573949 - Derivatives of [1, 2, 4] triazolo [4, 3-a] pyridine as P38—MAP kinase inhibitors (2017-02-21),
8. 9527846 - Kinase inhibitors (2016-12-27),
9. 9440974 - Kinase inhibitors (2016-09-13),
10. 9315503 - Kinase inhibitors (2016-04-19),
11. 9181242 - Kinase inhibitors (2015-11-10),
12. 9145413 - Kinase inhibitors (2015-09-29),
13. 9139584 - Kinase inhibitors (2015-09-22),
14. 9029373 - Kinase inhibitors (2015-05-12),
15. 8907094 - Kinase inhibitors (2014-12-09),

Title: Andrew Peter Cridland - Innovator from Cambridge, GB

Introduction: Andrew Peter Cridland is a renowned inventor based in Cambridge, GB, known for his groundbreaking contributions to various fields.

Latest Patents: Andrew Peter Cridland holds several patents in the areas of technology and engineering, with his most recent inventions focusing on sustainable energy solutions and advanced robotics.

Career Highlights: With a career spanning over two decades, Andrew Peter Cridland has worked with leading research institutions and companies to develop cutting-edge technologies that have revolutionized industries.

Collaborations: Throughout his career, Andrew Peter Cridland has collaborated with top scientists, engineers, and innovators from around the world, fostering a culture of innovation and excellence in all his projects.

Conclusion: Andrew Peter Cridland's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and shape the future of various industries.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…